
Men's Health
Latest News
Advertisement
Video Series

Latest Videos
Shorts

0:20
New guidelines recognize penoscrotal decompression for priapism
15 days ago
by
Juan J. Andino, MD, MBA

0:40
Challenging misconceptions about proximal shunting
a month ago
by
Juan J. Andino, MD, MBA

0:51
How to spot patients chasing a product, not a diagnosis
2 months ago
by
Jean Cunningham, PharmD, BCPS

0:51
Why GLP-1 and TRT combinations require careful sequencing
2 months ago
by
Jean Cunningham, PharmD, BCPS

0:49
How urologists can support the State of Men’s Health Act
2 months ago
by
Mark T. Edney, MD

0:41
Erectile dysfunction and cardiovascular health: An opportunity for urologists
3 months ago
by
Mark T. Edney, MD

0:36
Joshua Halpern, MD, on the advantages of mail-in semen analysis
3 months ago
by
Joshua Halpern, MD, MS

1:08
Janelle Bunce, PA-C, discusses a holistic approach to testosterone deficiency care
4 months ago
by
Janelle Bunce, PA-C

0:29
Joshua Halpern, MD, on what’s next in male fertility diagnostics
4 months ago
by
Joshua Halpern, MD, MS

0:54
Testosterone and prostate cancer risk: A balanced message
4 months ago
by
Helen L. Bernie, DO, MPH
Podcasts
CME Content
Advertisement
More News

Titan Prime will be available in the US via a phased launch beginning in late 2026.

With this expansion, the platform now represents a comprehensive automated testosterone testing solution.

A recap of the FDA submissions and regulatory decisions in urology from April 2026.

Akanksha Mehta, MD, MS, discusses why the updated vasectomy guideline expands its focus on fertility restoration, emphasizing patient counseling on reversal and individualized decision-making for future family building.

Helen L. Bernie, DO, MPH, discusses how expanded TRT labeling could improve care for men with idiopathic hypogonadism.
Advertisement
Advertisement
Trending on Urology Times
1
Treatment interruptions in prostate cancer: Balancing PSA kinetics and quality of life
2
Cretostimogene reduces recurrence risk by 68% in phase 3 PIVOT-006 trial in NMIBC
3
Rethinking Testosterone Therapy After the FDA Label Revisions
4
American Cancer Society updates prostate cancer screening guidelines, recommends regular PSA testing
5
























